Biochemical characterisation of amyloid by endomyocardial biopsy

References

• Kushwaha S S, Fallon J T, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336: 267–276
   PubMedGoogle Scholar
• Kyle R A, Gertz M A. Systemic amyloidosis. Crit Rev Oncol Hematol 1990; 10: 49–87
   PubMed Web of Science ®Google Scholar
• Benson M D. The hereditary amyloidoses. Best practice and research clinical rheumatology. Elsevier, UK 2003; 17: 909–927, Chapter 2
   Google Scholar
• Kyle R A, Spittell P C, Gertz M A, Li C-Y, Edwards W D, Olson L J, Thobodeau S N. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996; 101: 395–400
   PubMed Web of Science ®Google Scholar
• Ng B, Connors L H, Davidoff R, Skinner M, Falk R H. Senile systemic amyloidosis presenting with heart failure. Arch Intern Med 2005; 165: 1425–1429
   PubMed Web of Science ®Google Scholar
• Skinner M, Sanchorawala V, Seldin D C, Dember L M, Falk R H, Berk J L, Anderson J J, O'Hara C, Finn K T, Libbey C A, Wiesman J, Quillen K, Swan W, Wright D G. High-dose Melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004; 140: 85–93
   PubMed Web of Science ®Google Scholar
• Lachmann H J, Booth D R, Booth S E, Bybee A, Gilbertson J A, Gillmore J D, Pepys M B, Hawkins P N. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 346: 1786–1791
   PubMed Web of Science ®Google Scholar
• Comenzo R L, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood 2006; 107: 3489–3491
   PubMed Web of Science ®Google Scholar
• Cunningham K S, Veinot J P, Butany J. An approach to endomyocardial biopsy interpretation. J Clin Pathol 2006; 59: 121–129
   Web of Science ®Google Scholar
• Liepnieks J J, Benson M D. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid J Protein Folding Dis 2007; 14: 277–282
   PubMed Web of Science ®Google Scholar
• Hamidi Asl L, Liepnieks J J, Hamidi Asl K, Uemichi T, Moulin G, Desjoyaux E, Loire R, Delpech M, Grateau G, Benson M D. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999; 154: 221–227
   PubMed Web of Science ®Google Scholar
• Yazaki M, Liepnieks J J, Barats M S, Cohen A H, Benson M D. Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 2003; 64: 11–16
   PubMed Web of Science ®Google Scholar
• Rahman J E, Helou E F, Gelzer-Bell R, Thompson R E, Kuo C, Rodriguez E R, Hare J M, Baughman K L, Kasper E K. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004; 43: 410–415
   PubMed Web of Science ®Google Scholar
• Sallach J A, Klein A L. Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr Opin Cardiol 2004; 19: 464–471
   PubMed Web of Science ®Google Scholar
• Oki T, Tanaka H, Yamada H, Tabata T, Oishi Y, Ishimoto T, et al. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol 2004; 93: 864–869
   PubMedGoogle Scholar
• Kristen A V, Meyer F J, Perz J B, Schonland S O, Hundemer M, Hegenbart U, Singer R, Schnabel P A, Sack F U, Goldschmidt H, Katus H A, Dengler T J. Risk stratification in cardiac amyloidosis: novel approaches. Transplantation 2005; 80: S151–S155
   PubMed Web of Science ®Google Scholar
• Anesi E, Palladini G, Perfetti V, Arbustini E, Obici L, Merlini G. Therapeutic advances demand accurate typing of amyloid deposits. Am J Med 2001; 111: 243–244
   PubMed Web of Science ®Google Scholar
• Benson M D. Amyloidosis. The metabolic and molecular bases of inherited disease. 8th ed, C R Scriver, A L Beaudet, W S Sly, D Valle, B Childs, K W Kinzler, B Vogelstein. McGraw Hill Book Co, New York, NY 2001; IV: 5345–5378, Chapter 209, Part 22 Connective tissue
   Google Scholar
• Kingsbury J S, Théberge R, Karbassi J A, Lim A, Costello C E, Connors L H. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry. Anal Chem 2007; 79: 1990–1998
   PubMed Web of Science ®Google Scholar
• Murphy C L, Wang S, Williams T, Weiss D T, Solomon A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol 2006; 412: 48–62
   PubMed Web of Science ®Google Scholar